Hsp90 blockers inhibit adipocyte differentiation and fat mass accumulation.
Geldanamycin derivatives are benzoquinone ansamycin antibiotics that bind to Hsp90 and alter its function. The alteration of Hsp90 activity limits some cellular hormonal responses by inhibiting nuclear receptors activation. The nuclear receptors activity, such as PPARγ, the mineralocorticoid and glu...
Main Authors: | Sébastien Desarzens, Wan-Hui Liao, Caterina Mammi, Massimiliano Caprio, Nourdine Faresse |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3976389?pdf=render |
Similar Items
-
Inhibition of Hsp90 in Streptomyces coelicolor
by: Wu, Katherine A. (Katherine Ann)
Published: (2007) -
The universe of Hsp90
by: Stankiewicz Marta, et al.
Published: (2012-02-01) -
C0818, a novel curcumin derivative, interacts with Hsp90 and inhibits Hsp90 ATPase activity
by: Yingjuan Fan, et al.
Published: (2017-01-01) -
Molecular characterization of the Hsp70/Hsp90 organizing protein (Hop) phosphorylation, subcellular localization and interaction with Hsp90
by: Daniel, Sheril
Published: (2008) -
The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
by: Li Zihai, et al.
Published: (2010-10-01)